Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02700724 · ClinicalTrials.gov registry record · NA

Observation Versus Immediate Surgery of Low Risk Bladder Cancer

A NA study, sponsored by Vanderbilt University Medical Center.

Terminated
Registry status
NA
Development phase
8
Enrollment target

NCT02700724 is a NA study that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 8 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02700724, a NA study, was terminated before completion, sponsored by Vanderbilt University Medical Center.

TERMINATED
Registry status
NA
Development phase
8 participants
Enrollment target

Study Summary

This trial is a randomized, multi-center, non-inferiority study comparing observation versus immediate surgery for low grade, noninvasive bladder cancer.

Interventions

  • OTHER Observation
  • OTHER Immediate Surgery
  • PROCEDURE Surveillance Cystoscopy and Urinary Cytology

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2016-04
Est. Completion 2018-07-19
Phase NA

What the Registry Record Tells You About NCT02700724

The ClinicalTrials.gov registry entry for NCT02700724 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Observation is the first listed.

NCT02700724 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02700724 about?

NCT02700724 is a clinical study titled "Observation Versus Immediate Surgery of Low Risk Bladder Cancer". This trial is a randomized, multi-center, non-inferiority study comparing observation versus immediate surgery for low grade, noninvasive bladder cancer.

What is the current status of trial NCT02700724?

This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2016-04. Estimated completion is 2018-07-19.

What interventions are being tested in trial NCT02700724?

The interventions under investigation include: Observation (OTHER), Immediate Surgery (OTHER), Surveillance Cystoscopy and Urinary Cytology (PROCEDURE).

Who is sponsoring clinical trial NCT02700724?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.